ATE318176T1 - Verfahren zur entfernung von hiv und anderen viren aus blut - Google Patents

Verfahren zur entfernung von hiv und anderen viren aus blut

Info

Publication number
ATE318176T1
ATE318176T1 AT99945196T AT99945196T ATE318176T1 AT E318176 T1 ATE318176 T1 AT E318176T1 AT 99945196 T AT99945196 T AT 99945196T AT 99945196 T AT99945196 T AT 99945196T AT E318176 T1 ATE318176 T1 AT E318176T1
Authority
AT
Austria
Prior art keywords
blood
viruses
removal
viral
hiv
Prior art date
Application number
AT99945196T
Other languages
English (en)
Inventor
Julian L Ambrus
David O Scamurra
Original Assignee
Julian L Ambrus
David O Scamurra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Julian L Ambrus, David O Scamurra filed Critical Julian L Ambrus
Application granted granted Critical
Publication of ATE318176T1 publication Critical patent/ATE318176T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99945196T 1998-08-31 1999-08-30 Verfahren zur entfernung von hiv und anderen viren aus blut ATE318176T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9847798P 1998-08-31 1998-08-31

Publications (1)

Publication Number Publication Date
ATE318176T1 true ATE318176T1 (de) 2006-03-15

Family

ID=22269457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945196T ATE318176T1 (de) 1998-08-31 1999-08-30 Verfahren zur entfernung von hiv und anderen viren aus blut

Country Status (7)

Country Link
US (1) US6528057B1 (de)
EP (1) EP1109564B1 (de)
AT (1) ATE318176T1 (de)
AU (1) AU770344B2 (de)
CA (1) CA2342203C (de)
DE (1) DE69929986T2 (de)
WO (1) WO2000012103A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US8197430B1 (en) * 1998-05-22 2012-06-12 Biopheresis Technologies, Inc. Method and system to remove cytokine inhibitor in patients
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
AR028039A1 (es) 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
US7306902B2 (en) * 2002-06-28 2007-12-11 Oncolyties Biotech Inc. Oncolytic viruses as phenotyping agents for neoplasms
US8491884B2 (en) 2000-05-03 2013-07-23 Oncolytics Biotech Inc. Virus clearance of neoplastic cells from mixed cellular compositions
AR028040A1 (es) * 2000-05-03 2003-04-23 Oncolytics Biotech Inc Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
US8865172B2 (en) * 2000-05-08 2014-10-21 Advanced Extravascular Systems, Inc. Method for reducing the number of unwanted molecules in bodily fluids
US7465540B2 (en) * 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
WO2004024099A2 (en) * 2002-04-02 2004-03-25 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
RU2353399C2 (ru) * 2003-01-17 2009-04-27 Этлон Медикал, Инк. Способ удаления вирусов из крови посредством лектин-аффинного гемодиализа
US20040259076A1 (en) * 2003-06-23 2004-12-23 Accella Scientific, Inc. Nano and micro-technology virus detection method and device
DK1737428T3 (en) * 2004-03-31 2017-10-09 Univ Utah Res Found MACROMOLECULAR ADMINISTRATION SYSTEMS FOR NON-INVASIVE IMAGING, EVALUATION AND TREATMENT OF ARTHRITIS AND OTHER INFLAMMATORY DISEASES
AU2005240082B2 (en) * 2004-04-30 2009-07-23 Innatus Corporation Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients
EP1799840A4 (de) 2004-09-03 2009-02-18 Univ Columbia Ilt3-polypeptide und verwendungen davon
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US20090202544A1 (en) * 2006-02-02 2009-08-13 The Trustees Of Columbia University In The City Of New York Methods of Treating Diseases by Targeting Silt3
CA2644855C (en) 2006-03-09 2019-11-19 Aethlon Medical, Inc. Extracorporeal removal of microvesicular particles
WO2008108980A2 (en) * 2007-03-01 2008-09-12 Nanospectra Biosciences, Inc. Devices and methods for extracorporeal ablation of circulating cells
WO2009023332A2 (en) * 2007-05-16 2009-02-19 Aethlon Medical, Inc. Device and method for purifying virally infected blood
EP2238079A4 (de) * 2007-12-27 2014-07-02 Aethlon Medical Inc Verfahren und vorrichtung zur erhöhung der fremdstoff-clearance-raten bei der extrakorporalen fluidbehandlung
US20110218512A1 (en) * 2008-06-03 2011-09-08 Aethlon Medical, Inc. Enhanced antiviral therapy methods and devices
AU2014259591B2 (en) * 2008-06-13 2016-03-03 Elster Solutions, Llc Techniques for limiting demand from an electricity meter with an installed relay
WO2010014702A1 (en) * 2008-07-29 2010-02-04 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
WO2011046504A1 (en) * 2009-10-18 2011-04-21 Glycorex Ab Method and product for blood treatment and purification
US20130203061A1 (en) 2009-11-30 2013-08-08 Michael KLASS Methods and systems for isolating, storing, and analyzing vesicles
US9694128B1 (en) * 2010-02-24 2017-07-04 Brian LeBerthon Device and method for administering an anti-cancer substance
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
WO2013033734A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Diagnosis and Treatment of Cancer Expressing ILT3 or ILT3 Ligand
US9227005B2 (en) 2013-03-14 2016-01-05 Brian J LeBerthon Method and device for treating cancer
US20170035955A1 (en) * 2015-03-27 2017-02-09 Eliaz Therapeutics, Inc. Apheresis based treatment for kidney disease
US10765742B2 (en) 2015-07-17 2020-09-08 The Trustees Of Columbia University In The City Of New York Methods of treating CD166-expressing cancer
CN106267416B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病治疗仪
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
US10786614B2 (en) * 2016-10-24 2020-09-29 Henley Development Corporation Antigenic decoy entrapment filtration device and treatment methods for autoimmune disorders
ES2913665T3 (es) 2017-09-18 2022-06-03 Santersus Ag Método y dispositivo para la purificación de sangre a partir de ADN celular libre en circulación
CN108653847A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离艾滋病病毒免疫吸附器
CN108653846A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离蛋白a免疫吸附器
CN108653848A (zh) * 2018-02-11 2018-10-16 武汉瑞法医疗器械有限公司 一体式血浆分离IgE免疫吸附器
CN108283738A (zh) * 2018-02-11 2018-07-17 武汉瑞法医疗器械有限公司 一体式血浆分离dna免疫吸附器
DE202018102428U1 (de) 2018-05-02 2019-02-28 Aleksandr A. Buslaev Elektrochemisches Einwirksystem auf den HIV-Virus im menschlichen Körper mittels Kathodenstrom
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4787974A (en) * 1981-06-29 1988-11-29 Ambrus Clara M Blood purification
US4612122A (en) 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US4668399A (en) * 1982-02-16 1987-05-26 E. I. Du Pont De Nemours And Company Hollow fiber plasmapheresis process
US5041079A (en) * 1987-12-04 1991-08-20 Kuraray Co., Ltd. Method for removing human immunodeficiency virus and/or its related compounds
US5123901A (en) * 1988-02-25 1992-06-23 Carew E Bayne Method for separating pathogenic or toxic agents from a body fluid and return to body
WO1993004732A1 (en) * 1991-09-09 1993-03-18 The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Methods and devices for treating hemophilia and aids
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same

Also Published As

Publication number Publication date
CA2342203C (en) 2011-03-01
DE69929986T2 (de) 2006-10-19
WO2000012103A1 (en) 2000-03-09
DE69929986D1 (de) 2006-04-27
AU770344B2 (en) 2004-02-19
EP1109564A4 (de) 2003-05-02
US6528057B1 (en) 2003-03-04
AU5785299A (en) 2000-03-21
EP1109564B1 (de) 2006-02-22
CA2342203A1 (en) 2000-03-09
EP1109564A1 (de) 2001-06-27

Similar Documents

Publication Publication Date Title
ATE318176T1 (de) Verfahren zur entfernung von hiv und anderen viren aus blut
DE60025529D1 (de) Magnetische glasteilchen, herstellungsverfahren und benutzung
WO2004064608A3 (en) Method for removal of viruses from blood by lectin affinity hemodialysis
ATE419629T1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
BR9710709A (pt) Estruturas de carbono porosas e rigidas processos de fabrica-Æo processos de uso e produtos que as cont-m
ATE325613T1 (de) Apherese von leukozyten aus blut zur behandlung von hiv
DE602006019111D1 (de) Verfahren zur isolierung von analyten aus einer probe
ATE186900T1 (de) Verfahren zur aeroben, weitergehenden biologischen reinigung von abwässern
ATE491790T1 (de) Isolierung und reinigung von nucleinsäuren
DE69722491D1 (de) Adsorbens und Verfahren zur Entfernung von Chemokinen des CC-Subtyps aus Körperflüssigkeiten
ATE488582T1 (de) Verfahren zur reinigung von faktor ix
DE60209095D1 (de) Verfahren zur Rückgewinnung von Katalysatormetallen
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
ATE298889T1 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
ATE314391T1 (de) Methode zur reinigung von thrombopoietin
ATE401424T1 (de) Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele
DE60203975D1 (de) Verfahren zur Herstellung von magnetischen Teilchen, magnetische Teilchen und magnetischer Werkstoff
DE50208601D1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
DE59102062D1 (de) Verfahren zur biologischen Reinigung von Abluftströmen.
ATE434036T1 (de) Filtrationsverfahren zur trennung von viren
EP1679117A3 (de) Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma
NO20004071L (no) Karbonfiberfiltre
DK1242816T3 (da) Kromatografimateriale og fremgangsmåder ved anvendelse af dette
DE60231701D1 (de) Ammoniumsulfat zur aufhebung von inhibitorischen effekten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties